Literature DB >> 2827825

Pharmacological analysis of the calcium-dependence of mu-receptor agonism.

I G Dougall1, P Leff.   

Abstract

1 A number of studies in isolated tissues have shown that mu-opioid-receptor-mediated agonism can be augmented or potentiated with reduction in extracellular calcium concentration [( Ca2+]o). These effects have been ascribed to alterations in post-receptor coupling but the nature of the changes involved have not been quantitatively elucidated. 2 In this paper, logistic curve-fitting and operational model-fitting (Black & Leff, 1983) were used to analyse the effects of variations in [Ca2+]o on the mu-receptor-mediated effects of [D-Ala2, MePhe4, Gly-ol5]enkephalin (DAGOL) in the isolated, coaxially-stimulated ileum of the guinea-pig. At each value of [Ca2+]o, the effects of irreversible receptor alkylation by beta-chlornaltrexamine (beta-CNA) were also investigated. 3 From these analyses it is concluded that with reduction in [Ca2+]o the efficacy of DAGOL in this system is increased and the sensitivity of the transducer relation is also enhanced, the latter indicating a trend towards positive co-operativity. Reduction of [Ca2+]o also appeared to produce a reduction in agonist affinity. 4 Experimental manipulation of [Ca2+]o may provide a useful means of enhancing mu-agonist efficacy, allowing detection of agonism in compounds with low intrinsic efficacies. However, the accompanying change in co-operativity of the transducer relation must be considered when quantifying agonism under these conditions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2827825      PMCID: PMC1853726          DOI: 10.1111/j.1476-5381.1987.tb11376.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Pharmacological analysis of the interaction between Bay K 8644 and 5-HT in rabbit aorta.

Authors:  V J Barrett; P Leff; G R Martin; P J Richardson
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

2.  Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties.

Authors:  P S Portoghese; D L Larson; J B Jiang; T P Caruso; A E Takemori
Journal:  J Med Chem       Date:  1979-02       Impact factor: 7.446

3.  Quantification of H2-agonism by clonidine and dimaprit in an adenylate cyclase assay.

Authors:  D G Trist; P Leff
Journal:  Agents Actions       Date:  1985-04

4.  Operational models of pharmacological agonism.

Authors:  J W Black; P Leff
Journal:  Proc R Soc Lond B Biol Sci       Date:  1983-12-22

5.  Pharmacological analysis of beta-adrenoceptor-mediated agonism in the guinea-pig, isolated, right atrium.

Authors:  J W Black; V P Gerskowitch; P Leff; N P Shankley
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

6.  Chloroxymorphamine, and opioid receptor site-directed alkylating agent having narcotic agonist activity.

Authors:  T P Caruso; A E Takemori; D L Larson; P S Portoghese
Journal:  Science       Date:  1979-04-20       Impact factor: 47.728

7.  Differential involvement of calcium in acute and chronic opioid action in the guinea-pig ileum in vitro.

Authors:  F A Opmeer; J M Van Ree
Journal:  J Pharmacol Exp Ther       Date:  1980-04       Impact factor: 4.030

8.  Competitive antagonism of morphine action in vitro by calcium.

Authors:  F A Opmeer; J M Van Ree
Journal:  Eur J Pharmacol       Date:  1979-02-01       Impact factor: 4.432

9.  Pharmacological characterization of the opioid receptor in the submucous plexus of the guinea-pig oesophagus.

Authors:  Y Kamikawa; Y Shimo
Journal:  Br J Pharmacol       Date:  1983-04       Impact factor: 8.739

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  7 in total

1.  Characterization of the ORL(1) receptor on adrenergic nerves in the rat anococcygeus muscle.

Authors:  M Ho; A D Corbett; A T McKnight
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

2.  Modelling the changes induced by chronic desipramine treatment on the factors governing the agonism at prejunctional alpha 2-adrenoceptors.

Authors:  J Sallés; J Giraldo; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

3.  Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions.

Authors:  M Dierssen; J Flórez; M A Hurlé
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

4.  Estimation of affinities and efficacies for kappa-receptor agonists in guinea-pig ileum.

Authors:  P Leff; I G Dougall
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

5.  Action of purine and pyrimidine nucleotides on the rat superior cervical ganglion.

Authors:  G P Connolly; P J Harrison; T W Stone
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Estimation of opioid receptor agonist dissociation constants with beta-chlornaltrexamine, an irreversible ligand which also displays agonism.

Authors:  P Leff; I G Dougall
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

7.  Characterization of the adenosine receptors of the rat superior cervical ganglion.

Authors:  G P Connolly; T W Stone; F Brown
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.